{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:06:59Z","timestamp":1789409219231,"version":"build-2803163510"},"reference-count":69,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2016.00100","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T22:46:03Z","timestamp":1467153963000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Opposite Interplay between PPAR Gamma and Canonical Wnt\/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Yves","family":"Lecarpentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1172\/JCI27751","article-title":"Suppression of canonical Wnt\/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy","volume":"116","author":"Garcia-Gras","year":"2006","journal-title":"J Clin Invest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1210\/en.143.6.2106","article-title":"Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"143","author":"Gerhold","year":"2002","journal-title":"Endocrinology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1128\/MCB.00441-06","article-title":"Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin","volume":"26","author":"Liu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejphar.2010.03.010","article-title":"Repression of beta-catenin signaling by PPAR gamma ligands","volume":"636","author":"Lu","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj20030426","article-title":"Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis","volume":"376","author":"Moldes","year":"2003","journal-title":"Biochem J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35583","DOI":"10.1074\/jbc.M403143200","article-title":"Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway","volume":"279","author":"Sharma","year":"2004","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","article-title":"Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis","volume":"5","author":"Takada","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fphys.2014.00429","article-title":"Circadian rhythms, Wnt\/beta-catenin pathway and PPAR alpha\/gamma profiles in diseases with primary or secondary cardiac dysfunction","volume":"5","author":"Lecarpentier","year":"2014","journal-title":"Front Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35899","DOI":"10.1074\/jbc.M112.366419","article-title":"The peroxisome proliferator-activated receptor gamma (PPARgamma) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis","volume":"287","author":"Benedusi","year":"2012","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/hmg\/ddu587","article-title":"PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43","volume":"24","author":"Joardar","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"418765","DOI":"10.1155\/2008\/418765","article-title":"Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and huntington\u2019s disease","volume":"2008","author":"Kiaei","year":"2008","journal-title":"PPAR Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Schutz","year":"2005","journal-title":"J Neurosci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mus.22217","article-title":"PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model","volume":"44","author":"Liang","year":"2011","journal-title":"Muscle Nerve"},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1326-6-51","article-title":"Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis","volume":"6","author":"Zhao","year":"2011","journal-title":"Mol Neurodegener"},{"key":"B15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2012.03.006","article-title":"Activation of the Wnt\/beta-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice","volume":"420","author":"Chen","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1179\/1743132812Y.0000000027","article-title":"Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice","volume":"34","author":"Chen","year":"2012","journal-title":"Neurol Res"},{"key":"B17","first-page":"1245","article-title":"Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice","volume":"6","author":"Li","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s10529-013-1199-1","article-title":"Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice","volume":"35","author":"Wang","year":"2013","journal-title":"Biotechnol Lett"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.chembiol.2010.08.012","article-title":"Chemical-genetic screen identifies riluzole as an enhancer of Wnt\/beta-catenin signaling in melanoma","volume":"17","author":"Biechele","year":"2010","journal-title":"Chem Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/B978-0-12-385883-2.00002-3","article-title":"The complex molecular biology of amyotrophic lateral sclerosis (ALS)","volume":"107","author":"Redler","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/364362c0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"364","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pneurobio.2008.01.001","article-title":"Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS","volume":"85","author":"Turner","year":"2008","journal-title":"Prog Neurobiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/riluzole study group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis\/riluzole study group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/14660820310002601","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"4","author":"Miller","year":"2003","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"CD001447","DOI":"10.1002\/14651858.CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-2094-9-63","article-title":"The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function","volume":"9","author":"Gray","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1006\/bbrc.1996.1044","article-title":"Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2","volume":"224","author":"Elbrecht","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"783273","DOI":"10.1155\/2010\/783273","article-title":"PPARs, cardiovascular metabolism, and function: near- or far-from-equilibrium pathways","volume":"2010","author":"Lecarpentier","year":"2010","journal-title":"PPAR Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.cmet.2008.10.009","article-title":"Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1","volume":"8","author":"Wang","year":"2008","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/iub.1097","article-title":"Peroxisome proliferator-activated receptor-gamma cofactors in neurodegeneration","volume":"64","author":"Katsouri","year":"2012","journal-title":"IUBMB Life"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/sj.jcbfm.9600438","article-title":"Ischemic preconditioning reveals that GLT1\/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection","volume":"27","author":"Romera","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nrd2154","article-title":"Mining the Wnt pathway for cancer therapeutics","volume":"5","author":"Barker","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","article-title":"The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway","volume":"96","author":"Shtutman","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1073\/pnas.0405928102","article-title":"The Wnt\/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells","volume":"102","author":"Jansson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cvr\/cvp183","article-title":"A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy","volume":"84","author":"Djouadi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.1071549","article-title":"The promise and perils of Wnt signaling through beta-catenin","volume":"296","author":"Moon","year":"2002","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0955-0674(98)80039-2","article-title":"Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer","volume":"10","author":"Ben-Ze\u2019ev","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1128\/MCB.20.12.4238-4252.2000","article-title":"Differential mechanisms of LEF\/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin","volume":"20","author":"Zhurinsky","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR-gamma) and neurodegenerative disorders","volume":"46","author":"Chen","year":"2012","journal-title":"Mol Neurobiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1440-1789.2008.00890.x","article-title":"Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"28","author":"Shibata","year":"2008","journal-title":"Neuropathology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1523\/JNEUROSCI.5857-08.2009","article-title":"Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia","volume":"29","author":"Zhao","year":"2009","journal-title":"J Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e37885","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/pds.3925","article-title":"Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue","volume":"25","author":"Faillie","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B51","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/me.2006-0152","article-title":"A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver","volume":"21","author":"Ciana","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.nbd.2012.07.004","article-title":"Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1alpha","volume":"51","author":"Song","year":"2013","journal-title":"Neurobiol Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cmet.2012.03.019","article-title":"Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS","volume":"15","author":"Da Cruz","year":"2012","journal-title":"Cell Metab"},{"key":"B54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/358771a0","article-title":"Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors","volume":"358","author":"Kliewer","year":"1992","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1046\/j.1471-4159.2000.0752511.x","article-title":"A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord","volume":"75","author":"Malaspina","year":"2000","journal-title":"J Neurochem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa070174","article-title":"Whole-genome analysis of sporadic amyotrophic lateral sclerosis","volume":"357","author":"Dunckley","year":"2007","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.20379","article-title":"Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis","volume":"57","author":"Jiang","year":"2005","journal-title":"Ann Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1242\/jcs.00169","article-title":"Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients","volume":"115","author":"Corcoran","year":"2002","journal-title":"J Cell Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"582075","DOI":"10.1155\/2012\/582075","article-title":"A pilot trial of pioglitazone HCl and tretinoin in ALS: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression","volume":"2012","author":"Levine","year":"2012","journal-title":"Neurol Res Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fncel.2015.00250","article-title":"Neuroprotective effect of bexarotene in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"9","author":"Riancho","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nurt.2008.08.002","article-title":"ALS drug development: reflections from the past and a way forward","volume":"5","author":"Aggarwal","year":"2008","journal-title":"Neurotherapeutics"},{"key":"B62","first-page":"147","article-title":"Drug therapy for amyotrophic lateral sclerosis: where are we now?","volume":"6","author":"Carter","year":"2003","journal-title":"IDrugs"},{"key":"B63","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1600-0501.2012.02488.x","article-title":"GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces","volume":"24","author":"Galli","year":"2013","journal-title":"Clin Oral Implants Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/dbio.1997.8552","article-title":"Activation of the Wnt signaling pathway: a molecular mechanism for lithium action","volume":"185","author":"Hedgepeth","year":"1997","journal-title":"Dev Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"F703","DOI":"10.1152\/ajprenal.00189.2004","article-title":"Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors","volume":"288","author":"Sinha","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/107385802237176","article-title":"The Wnt signaling pathway in bipolar disorder","volume":"8","author":"Gould","year":"2002","journal-title":"Neuroscientist"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2012.00001","article-title":"GSK-3 and Wnt signaling in neurogenesis and bipolar disorder","volume":"5","author":"Valvezan","year":"2012","journal-title":"Front Mol Neurosci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/00023210-200822090-00004","article-title":"Riluzole in the treatment of mood and anxiety disorders","volume":"22","author":"Pittenger","year":"2008","journal-title":"CNS Drugs"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T09:46:14Z","timestamp":1467798374000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fneur.2016.00100\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":69,"URL":"https:\/\/doi.org\/10.3389\/fneur.2016.00100","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}